|
ZBTB44 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.0560445547253E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.90600005065289E-10 |
| Normal-vs-Stage2 |
1.44089999998265E-06 |
| Normal-vs-Stage3 |
7.88469955992355E-10 |
| Normal-vs-Stage4 |
2.73110000170718E-08 |
| Stage1-vs-Stage2 |
6.950800E-01 |
| Stage1-vs-Stage3 |
1.783970E-01 |
| Stage1-vs-Stage4 |
1.900620E-01 |
| Stage2-vs-Stage3 |
5.814000E-01 |
| Stage2-vs-Stage4 |
4.665800E-01 |
| Stage3-vs-Stage4 |
8.020600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.05110373130424E-11 |
| Normal-vs-AfricanAmerican |
3.895700E-03 |
| Normal-vs-Asian |
7.28990000031793E-07 |
| Caucasian-vs-AfricanAmerican |
2.675200E-01 |
| Caucasian-vs-Asian |
8.241600E-01 |
| AfricanAmerican-vs-Asian |
3.851600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.49949949626682E-10 |
| Normal-vs-Female |
7.03409552826884E-11 |
| Male-vs-Female |
5.719400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.33600000138546E-09 |
| Normal-vs-Age(41-60Yrs) |
1.41090028549229E-10 |
| Normal-vs-Age(61-80Yrs) |
8.5751999945316E-09 |
| Normal-vs-Age(81-100Yrs) |
4.439400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.426800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.355400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.693220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.856800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.866800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.832000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.412020E-01 |
| Classical-VS-Follicular |
1.240850E-01 |
| Classical-VS-Other |
9.880400E-01 |
| Classical-VS-Normal |
1.32970001676114E-09 |
| Tall-VS-Follicular |
6.956000E-01 |
| Tall-VS-Other |
4.658400E-01 |
| Tall-VS-Normal |
2.80530000007495E-07 |
| Follicular-VS-Other |
6.519800E-01 |
| Follicular-VS-Normal |
2.39699999848852E-08 |
| Other-VS-Normal |
4.093900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.24149629149906E-11 |
| Normal-vs-N1 |
3.78209999984946E-08 |
| N0-vs-N1 |
6.416800E-01 |
|
|
